Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00397683 · ClinicalTrials.gov registry record · Phase 2
A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011)
A Phase 2 study, sponsored by Merck Sharp & Dohme.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00397683 is a Phase 2 study that was terminated before completion, run by Merck Sharp & Dohme. The registered enrollment target is 2 participants.
The verdict
NCT00397683, a Phase 2 study, was terminated before completion, sponsored by Merck Sharp & Dohme.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to test MK0822 on disease activity in patients with osteoarthritis in the knee. Disease modifying activity of MK0822 will be assessed by measurements of knee cartilage using Magnetic Resonance Imaging (MRI) of the knee. This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
Interventions
- DRUG MK0822
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00397683
The ClinicalTrials.gov registry entry for NCT00397683 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MK0822 is the first listed.
NCT00397683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00397683 about?
NCT00397683 is a clinical study titled "A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011)". The purpose of this study is to test MK0822 on disease activity in patients with osteoarthritis in the knee. Disease modifying activity of MK0822 will be assessed by measurements of knee cartilage using Magnetic Resonance Imaging (MRI) of the knee. This is an early phase trial and some specific pro...
What is the current status of trial NCT00397683?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2006-10. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00397683?
The interventions under investigation include: MK0822 (DRUG).
Who is sponsoring clinical trial NCT00397683?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.